Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

CCR Translations

  • CCR Translations
    Turmeric and Green Tea: A Recipe for the Treatment of B-Chronic Lymphocytic Leukemia
    Laura S. Angelo and Razelle Kurzrock
    Clin Cancer Res February 15 2009 15 (4) 1123-1125; DOI:10.1158/1078-0432.CCR-08-2791

Molecular Pathways

  • Molecular Pathways
    Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
    Min H. Kang and C. Patrick Reynolds
    Clin Cancer Res February 15 2009 15 (4) 1126-1132; DOI:10.1158/1078-0432.CCR-08-0144

  • Molecular Pathways
    Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
    Pierre Laurent-Puig, Astrid Lievre and Hélène Blons
    Clin Cancer Res February 15 2009 15 (4) 1133-1139; DOI:10.1158/1078-0432.CCR-08-0905

Review

  • Review
    Role of ADAMs in Cancer Formation and Progression
    Michael J. Duffy, Eadaoin McKiernan, Norma O'Donovan and Patricia M. McGowan
    Clin Cancer Res February 15 2009 15 (4) 1140-1144; DOI:10.1158/1078-0432.CCR-08-1585

Human Cancer Biology

  • Human Cancer Biology
    IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer
    Judy W. King, Sharyn Thomas, Fabrizio Corsi, Liquan Gao, Roberto Dina, Roopinder Gillmore, Katharine Pigott, Amir Kaisary, Hans J. Stauss and Jonathan Waxman
    Clin Cancer Res February 15 2009 15 (4) 1145-1154; DOI:10.1158/1078-0432.CCR-08-1821

  • Human Cancer Biology
    Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
    Krishan Kumar, Hassan Brim, Francis Giardiello, Duane T. Smoot, Mehdi Nouraie, Edward L. Lee and Hassan Ashktorab
    Clin Cancer Res February 15 2009 15 (4) 1155-1161; DOI:10.1158/1078-0432.CCR-08-1029

  • Human Cancer Biology
    Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
    Tobias Klatte, Allan J. Pantuck, Jonathan W. Said, David B. Seligson, Nagesh P. Rao, Jeffrey C. LaRochelle, Brian Shuch, Amnon Zisman, Fairooz F. Kabbinavar and Arie S. Belldegrun
    Clin Cancer Res February 15 2009 15 (4) 1162-1169; DOI:10.1158/1078-0432.CCR-08-1229

  • Human Cancer Biology
    Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry
    Yoshinobu Komai, Mutsunori Fujiwara, Yasuhisa Fujii, Hiroyuki Mukai, Junji Yonese, Satoru Kawakami, Shinya Yamamoto, Toshiro Migita, Yuichi Ishikawa, Morito Kurata, Takuro Nakamura and Iwao Fukui
    Clin Cancer Res February 15 2009 15 (4) 1170-1176; DOI:10.1158/1078-0432.CCR-08-1183

  • Human Cancer Biology
    Uncovering Growth-Suppressive MicroRNAs in Lung Cancer
    Xi Liu, Lorenzo F. Sempere, Fabrizio Galimberti, Sarah J. Freemantle, Candice Black, Konstantin H. Dragnev, Yan Ma, Steven Fiering, Vincent Memoli, Hua Li, James DiRenzo, Murray Korc, Charles N. Cole, Mads Bak, Sakari Kauppinen and Ethan Dmitrovsky
    Clin Cancer Res February 15 2009 15 (4) 1177-1183; DOI:10.1158/1078-0432.CCR-08-1355

  • Human Cancer Biology
    Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
    Kimberly Laskie Ostrow, Hannah Lui Park, Mohammad Obaidul Hoque, Myoung Sook Kim, Junwei Liu, Pedram Argani, William Westra, Wim Van Criekinge and David Sidransky
    Clin Cancer Res February 15 2009 15 (4) 1184-1191; DOI:10.1158/1078-0432.CCR-08-1304

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Combining the Endoplasmic Reticulum Stress–Inducing Agents Bortezomib and Fenretinide as a Novel Therapeutic Strategy for Metastatic Melanoma
    David S. Hill, Shaun Martin, Jane L. Armstrong, Ross Flockhart, Joge J. Tonison, Dominic G. Simpson, Mark A. Birch-Machin, Christopher P.F. Redfern and Penny E. Lovat
    Clin Cancer Res February 15 2009 15 (4) 1192-1198; DOI:10.1158/1078-0432.CCR-08-2150

  • Cancer Therapy: Preclinical
    The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
    Gabriella Pagnan, Daniela Di Paolo, Roberta Carosio, Fabio Pastorino, Danilo Marimpietri, Chiara Brignole, Annalisa Pezzolo, Monica Loi, Luis J.V. Galietta, Federica Piccardi, Michele Cilli, Beatrice Nico, Domenico Ribatti, Vito Pistoia and Mirco Ponzoni
    Clin Cancer Res February 15 2009 15 (4) 1199-1209; DOI:10.1158/1078-0432.CCR-08-2477

  • Cancer Therapy: Preclinical
    Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
    Constantine S. Mitsiades, Cecile Rouleau, Cinara Echart, Krishna Menon, Beverly Teicher, Maria Distaso, Antonio Palumbo, Mario Boccadoro, Kenneth C. Anderson, Massimo Iacobelli and Paul G. Richardson
    Clin Cancer Res February 15 2009 15 (4) 1210-1221; DOI:10.1158/1078-0432.CCR-08-1270

  • Cancer Therapy: Preclinical
    Local Delivery of Poly Lactic-co-glycolic Acid Microspheres Containing Imatinib Mesylate Inhibits Intracranial Xenograft Glioma Growth
    Ofra Benny, Lata G. Menon, Gilert Ariel, Effrat Goren, Seung-Ki Kim, Chaney Stewman, Peter M. Black, Rona S. Carroll and Marcelle Machluf
    Clin Cancer Res February 15 2009 15 (4) 1222-1231; DOI:10.1158/1078-0432.CCR-08-1316

  • Cancer Therapy: Preclinical
    Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma
    Tulin Budak-Alpdogan, Bobin Chen, Anjali Warrier, Daniel J. Medina, Dirk Moore and Joseph R. Bertino
    Clin Cancer Res February 15 2009 15 (4) 1232-1240; DOI:10.1158/1078-0432.CCR-08-0810

  • Cancer Therapy: Preclinical
    Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
    Rachel A. Daniel, Agata L. Rozanska, Huw D. Thomas, Evan A. Mulligan, Yvette Drew, Deborah J. Castelbuono, Zdenek Hostomsky, E. Ruth Plummer, Alan V. Boddy, Deborah A. Tweddle, Nicola J. Curtin and Steven C. Clifford
    Clin Cancer Res February 15 2009 15 (4) 1241-1249; DOI:10.1158/1078-0432.CCR-08-1095

  • Cancer Therapy: Preclinical
    Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
    Asish K. Ghosh, Neil E. Kay, Charla R. Secreto and Tait D. Shanafelt
    Clin Cancer Res February 15 2009 15 (4) 1250-1258; DOI:10.1158/1078-0432.CCR-08-1511

  • Cancer Therapy: Preclinical
    High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis
    Irene H.L. Hamelers, Rutger W.H.M. Staffhorst, Jarno Voortman, Ben de Kruijff, Jan Reedijk, Paul M.P. van Bergen en Henegouwen and Anton I.P.M. de Kroon
    Clin Cancer Res February 15 2009 15 (4) 1259-1268; DOI:10.1158/1078-0432.CCR-08-1702

  • Cancer Therapy: Preclinical
    Soy-Derived Isoflavones Inhibit the Growth of Canine Lymphoid Cell Lines
    Vahbiz Jamadar-Shroff, Mark G. Papich and Steven E. Suter
    Clin Cancer Res February 15 2009 15 (4) 1269-1276; DOI:10.1158/1078-0432.CCR-08-1610

  • Cancer Therapy: Preclinical
    AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
    Marin Marinov, Algirdas Ziogas, Olivier E. Pardo, Liwen Terence Tan, Tony Dhillon, Francesco A. Mauri, Heidi A. Lane, Nicholas R. Lemoine, Uwe Zangemeister-Wittke, Michael J. Seckl and Alexandre Arcaro
    Clin Cancer Res February 15 2009 15 (4) 1277-1287; DOI:10.1158/1078-0432.CCR-08-2166

  • Cancer Therapy: Preclinical
    Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
    Pritish Pawar, Liping Ma, Chang Hyun Byon, Hui Liu, Eun-Young Ahn, Nirag Jhala, Juan P. Arnoletti, Jay M. McDonald and Yabing Chen
    Clin Cancer Res February 15 2009 15 (4) 1288-1296; DOI:10.1158/1078-0432.CCR-08-1150

  • Cancer Therapy: Preclinical
    Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis
    Erwan Pencreach, Eric Guérin, Céline Nicolet, Isabelle Lelong-Rebel, Anne-Claire Voegeli, Pierre Oudet, Annette K. Larsen, Marie-Pierre Gaub and Dominique Guenot
    Clin Cancer Res February 15 2009 15 (4) 1297-1307; DOI:10.1158/1078-0432.CCR-08-0889

  • Cancer Therapy: Preclinical
    Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy
    Maria Quanz, Nathalie Berthault, Christophe Roulin, Maryline Roy, Aurélie Herbette, Céline Agrario, Christophe Alberti, Véronique Josserand, Jean-Luc Coll, Xavier Sastre-Garau, Jean-Marc Cosset, Lionel Larue, Jian-Sheng Sun and Marie Dutreix
    Clin Cancer Res February 15 2009 15 (4) 1308-1316; DOI:10.1158/1078-0432.CCR-08-2108

  • Cancer Therapy: Preclinical
    Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
    Erica M. Gomes, Margret S. Rodrigues, Anagha P. Phadke, Lindsay D. Butcher, Cherry Starling, Salina Chen, Dongkun Chang, Ruben Hernandez-Alcoceba, Joseph T. Newman, Marvin J. Stone and Alex W. Tong
    Clin Cancer Res February 15 2009 15 (4) 1317-1325; DOI:10.1158/1078-0432.CCR-08-1360

  • Cancer Therapy: Preclinical
    Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
    Jing Lu, Ming Tan, Wen-Chien Huang, Ping Li, Hua Guo, Ling-Ming Tseng, Xiao-hua Su, Wen-Tao Yang, Warapen Treekitkarnmongkol, Michael Andreeff, Fraser Symmans and Dihua Yu
    Clin Cancer Res February 15 2009 15 (4) 1326-1334; DOI:10.1158/1078-0432.CCR-08-0954

  • Cancer Therapy: Preclinical
    Role of the Microenvironment for Radiosensitization by Patupilone
    Carla Rohrer Bley, Wolfram Jochum, Katrin Orlowski, Polina Furmanova, Van Vuong, Paul M.J. McSheehy and Martin Pruschy
    Clin Cancer Res February 15 2009 15 (4) 1335-1342; DOI:10.1158/1078-0432.CCR-08-0969

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
    Djordje Atanackovic, Tim Luetkens, York Hildebrandt, Julia Arfsten, Katrin Bartels, Christiane Horn, Tanja Stahl, Yanran Cao, Axel R. Zander, Carsten Bokemeyer and Nicolaus Kröger
    Clin Cancer Res February 15 2009 15 (4) 1343-1352; DOI:10.1158/1078-0432.CCR-08-0989

  • Imaging, Diagnosis, Prognosis
    A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival
    Eduardo Méndez, John R. Houck, David R. Doody, Wenhong Fan, Pawadee Lohavanichbutr, Tessa C. Rue, Bevan Yueh, Neal D. Futran, Melissa P. Upton, D. Gregory Farwell, Patrick J. Heagerty, Lue Ping Zhao, Stephen M. Schwartz and Chu Chen
    Clin Cancer Res February 15 2009 15 (4) 1353-1361; DOI:10.1158/1078-0432.CCR-08-1816

  • Imaging, Diagnosis, Prognosis
    Osteopontin Levels in an Asbestos-Exposed Population
    Eun-Kee Park, Paul S. Thomas, Anthony R. Johnson and Deborah H. Yates
    Clin Cancer Res February 15 2009 15 (4) 1362-1366; DOI:10.1158/1078-0432.CCR-08-0360

  • Imaging, Diagnosis, Prognosis
    A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
    Beatriz Sánchez-Espiridión, Abel Sánchez-Aguilera, Carlos Montalbán, Carmen Martin, Rafael Martinez, Joaquín González-Carrero, Concepción Poderos, Carmen Bellas, Manuel F. Fresno, Cesar Morante, Maria J. Mestre, Miguel Mendez, Francisco Mazorra, Eulogio Conde, Angel Castaño, Pedro Sánchez-Godoy, José F. Tomas, Manolo M. Morente, Miguel A. Piris and Juan F. García
    Clin Cancer Res February 15 2009 15 (4) 1367-1375; DOI:10.1158/1078-0432.CCR-08-1119

  • Imaging, Diagnosis, Prognosis
    Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer
    Andrew D. Darnel, Emy Behmoaram, Robin T. Vollmer, Jacques Corcos, Krikor Bijian, Kanishka Sircar, Jie Su, Jinsong Jiao, Moulay A. Alaoui-Jamali and Tarek A. Bismar
    Clin Cancer Res February 15 2009 15 (4) 1376-1383; DOI:10.1158/1078-0432.CCR-08-1789

  • Imaging, Diagnosis, Prognosis
    Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
    Iris Helfrich, Lutz Edler, Antje Sucker, Markus Thomas, Sven Christian, Dirk Schadendorf and Hellmut G. Augustin
    Clin Cancer Res February 15 2009 15 (4) 1384-1392; DOI:10.1158/1078-0432.CCR-08-1615

  • Imaging, Diagnosis, Prognosis
    Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients
    Wen Li, Chun-Ping Yu, Jin-tang Xia, Ling Zhang, Gui-Xiang Weng, Hai-qing Zheng, Qing-li Kong, Li-juan Hu, Mu-Sheng Zeng, Yi-xin Zeng, Mengfeng Li, Jun Li and Li-Bing Song
    Clin Cancer Res February 15 2009 15 (4) 1393-1399; DOI:10.1158/1078-0432.CCR-08-1158

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
    Karina Dalsgaard Sørensen, Peter Johannes Wild, Ashkan Mortezavi, Katja Adolf, Niels Tørring, Sara Heebøll, Benedicte Parm Ulhøi, Peter Ottosen, Tullio Sulser, Thomas Hermanns, Holger Moch, Michael Borre, Torben Falck Ørntoft and Lars Dyrskjøt
    Clin Cancer Res February 15 2009 15 (4) 1400-1410; DOI:10.1158/1078-0432.CCR-08-2268

  • Cancer Therapy: Clinical
    Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
    Nilofer S. Azad, Jeanny B. Aragon-Ching, William L. Dahut, Martin Gutierrez, William D. Figg, Lokesh Jain, Seth M. Steinberg, Maria L. Turner, Elise C. Kohn and Heidi H. Kong
    Clin Cancer Res February 15 2009 15 (4) 1411-1416; DOI:10.1158/1078-0432.CCR-08-1141

  • Cancer Therapy: Clinical
    Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
    Dariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, Craig Mermel, Joshy George, Gad Getz, Richard Tothill, Aikou Okamoto, Maria B. Raeder, AOCS Study Group, Paul Harnett, Stephen Lade, Lars A. Akslen, Anna V. Tinker, Bianca Locandro, Kathryn Alsop, Yoke-Eng Chiew, Nadia Traficante, Sian Fereday, Daryl Johnson, Stephen Fox, William Sellers, Mitsuyoshi Urashima, Helga B. Salvesen, Matthew Meyerson and David Bowtell
    Clin Cancer Res February 15 2009 15 (4) 1417-1427; DOI:10.1158/1078-0432.CCR-08-1564

  • Cancer Therapy: Clinical
    A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies
    Christine M. Hartford, Apurva A. Desai, Linda Janisch, Theodore Karrison, Victor M. Rivera, Lori Berk, John W. Loewy, Hedy Kindler, Walter M. Stadler, Heather L. Knowles, Camille Bedrosian and Mark J. Ratain
    Clin Cancer Res February 15 2009 15 (4) 1428-1434; DOI:10.1158/1078-0432.CCR-08-2076

  • Cancer Therapy: Clinical
    Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
    Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, Thomas Loh, Difeng Dong, Donny Soh, Lim-Soon Wong, Simon Green, Judy Chiao, Chun-Ying Cui, Yoke-Fong Lai, Soo-Chin Lee, Benjamin Mow, Richie Soong, Manuel Salto-Tellez and Boon-Cher Goh
    Clin Cancer Res February 15 2009 15 (4) 1435-1442; DOI:10.1158/1078-0432.CCR-08-1748

  • Cancer Therapy: Clinical
    Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
    John M. Kirkwood, Sandra Lee, Stergios J. Moschos, Mark R. Albertini, John C. Michalak, Cindy Sander, Theresa Whiteside, Lisa H. Butterfield and Louis Weiner
    Clin Cancer Res February 15 2009 15 (4) 1443-1451; DOI:10.1158/1078-0432.CCR-08-1231

  • Cancer Therapy: Clinical
    Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
    Nancy U. Lin, Véronique Diéras, Devchand Paul, Dominique Lossignol, Christos Christodoulou, Hans-Joachim Stemmler, Henri Roché, Minetta C. Liu, Richard Greil, Eva Ciruelos, Sibylle Loibl, Stefania Gori, Andrew Wardley, Denise Yardley, Adam Brufsky, Joanne L. Blum, Stephen D. Rubin, Bernie Dharan, Klaudia Steplewski, Denise Zembryki, Cristina Oliva, Debasish Roychowdhury, Paolo Paoletti and Eric P. Winer
    Clin Cancer Res February 15 2009 15 (4) 1452-1459; DOI:10.1158/1078-0432.CCR-08-1080

  • Cancer Therapy: Clinical
    Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
    Amye J. Tevaarwerk, Kyle D. Holen, Dona B. Alberti, Carolyn Sidor, Jamie Arnott, Check Quon, George Wilding and Glenn Liu
    Clin Cancer Res February 15 2009 15 (4) 1460-1465; DOI:10.1158/1078-0432.CCR-08-1599

  • Cancer Therapy: Clinical
    Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies
    William C. Zamboni, Suresh Ramalingam, David M. Friedland, Robert P. Edwards, Ronald G. Stoller, Sandra Strychor, Lauren Maruca, Beth A. Zamboni, Chandra P. Belani and Ramesh K. Ramanathan
    Clin Cancer Res February 15 2009 15 (4) 1466-1472; DOI:10.1158/1078-0432.CCR-08-1405

  • Cancer Therapy: Clinical
    Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
    Daisuke Aoki, Yoshinao Oda, Satoshi Hattori, Ken-ichi Taguchi, Yoshihiro Ohishi, Yuji Basaki, Shinji Oie, Nao Suzuki, Suminori Kono, Masazumi Tsuneyoshi, Mayumi Ono, Takashi Yanagawa and Michihiko Kuwano
    Clin Cancer Res February 15 2009 15 (4) 1473-1480; DOI:10.1158/1078-0432.CCR-08-1274

  • Cancer Therapy: Clinical
    Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer
    Eric Chen, Derek Jonker, Isabelle Gauthier, Martha MacLean, Julie Wells, Jean Powers and Lesley Seymour
    Clin Cancer Res February 15 2009 15 (4) 1481-1486; DOI:10.1158/1078-0432.CCR-08-0761

  • Cancer Therapy: Clinical
    Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients
    Liane M. McGlynn, Tove Kirkegaard, Joanne Edwards, Sian Tovey, David Cameron, Chris Twelves, John M.S. Bartlett and Timothy G. Cooke
    Clin Cancer Res February 15 2009 15 (4) 1487-1495; DOI:10.1158/1078-0432.CCR-07-4967

  • Cancer Therapy: Clinical
    Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
    Sukyung Woo, Erin R. Gardner, Xiaohong Chen, Sandra B. Ockers, Caitlin E. Baum, Tristan M. Sissung, Douglas K. Price, Robin Frye, Richard L. Piekarz, Susan E. Bates and William D. Figg
    Clin Cancer Res February 15 2009 15 (4) 1496-1503; DOI:10.1158/1078-0432.CCR-08-1215

Letters to the Editor

  • Letters to the Editor
    Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration–Resistant Prostate Cancer: Missing Parts in a Superb Study
    Gennadi V. Glinsky
    Clin Cancer Res February 15 2009 15 (4) 1504-1504; DOI:10.1158/1078-0432.CCR-08-2580

  • Letters to the Editor
    Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration–Resistant Prostate Cancer: Missing Parts in a Superb Study
    Johann S. de Bono, Christopher Parker, Howard I. Scher, R. Bruce Montgomery, M. Craig Miller, Henk Tissing, Gerald V. Doyle, Leon W.W.M. Terstappen, Kenneth J. Pienta and Derek Raghavan
    Clin Cancer Res February 15 2009 15 (4) 1504-1505; DOI:10.1158/1078-0432.CCR-09-0006

Corrections

  • Corrections
    Correction: Article on NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia
    Clin Cancer Res February 15 2009 15 (4) 1506-1506; DOI:10.1158/1078-0432.CCR-15-4-COR1

  • Corrections
    Correction: Article on Circulating Tumor Cells in Metastatic Prostate Cancer
    Clin Cancer Res February 15 2009 15 (4) 1506-1506; DOI:10.1158/1078-0432.CCR-15-4-COR2

Back to top
PreviousNext
Clinical Cancer Research: 15 (4)
February 2009
Volume 15, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
  • Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
  • Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies
  • High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis

Jump to

  • CCR Translations
  • Molecular Pathways
  • Review
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Letters to the Editor
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement